Industries

• Reset all ×
• Life Sciences ×
• 2021 ×

Showing 271–279 of 279 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Oncology Drug Market in China 2021

  The oncology drug market in China in terms of revenue is set to grow by US$ 42 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 13.8% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oncology drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Moderate and Severe Dry Eye Disease Market in China 2021

  The moderate and severe dry eye disease market in China in terms of revenue is set to grow by US$ 570 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the moderate and severe dry eye disease market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  NMOSD (Neuromyelitis Optica Spectrum Disorder) Drug Market in China 2021

  In terms of revenue, the NMOSD (neuromyelitis optica spectrum disorder) drug market in China is projected to grow at a compound annual growth rate (CAGR) of 26.8% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the NMOSD (neuromyelitis optica spectrum disorder) drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  MG (Myasthenia Gravis) Drug Market in China 2021

  The MG (myasthenia gravis) drug market in China in terms of revenue is set to grow by US$ 565 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 51% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the MG (myasthenia gravis) drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  ITP (Immune Thrombocytopenia) Drug Market in China 2021

  The ITP (immune thrombocytopenia) drug market in China in terms of revenue is set to grow by US$ 714 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 25.3% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the ITP (immune thrombocytopenia) drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Therapeutic Antibody Market in China 2021

  The therapeutic antibody market in China in terms of revenue is set to grow by US$ 41 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the therapeutic antibody market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Online Retail Pharmacy Market in China 2021

  The online retail pharmacy market in China in terms of revenue is set to grow by US$ 146 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 33.3% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the online retail pharmacy market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Digital Health and Wellness Market in China 2021

  The digital health and wellness market in China in terms of revenue is set to grow by US$ 199 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the digital health and wellness market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Health and Wellness Market in China 2021

  The health and wellness market in China in terms of revenue is set to grow by US$ 1,044 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the health and wellness market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450